301211 亨迪藥業
按盤價 
19.920 -1.070 (-5.098%)
19.920 -1.070 (-5.098%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.210 | 7.602 | 5.592 | 8.323 | 28.280 |
| 總資產報酬率 ROA (%) | 2.996 | 6.981 | 5.210 | 7.764 | 21.703 |
| 投入資產回報率 ROIC (%) | 3.165 | 7.409 | 5.477 | 8.244 | 26.103 | 邊際利潤分析 |
| 銷售毛利率 (%) | 30.232 | 40.172 | 28.878 | 33.943 | 49.650 |
| 營業利潤率 (%) | 24.838 | 30.969 | 28.884 | 25.764 | 33.556 |
| 息稅前利潤/營業總收入 (%) | 11.520 | 22.955 | 15.967 | 26.040 | 35.102 |
| 淨利潤/營業總收入 (%) | 22.354 | 26.562 | 24.430 | 22.502 | 28.346 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 84.948 | 96.296 | 94.033 | 84.775 | 96.151 |
| 價值變動淨收益/利潤總額(%) | 13.635 | 1.982 | 0.000 | 7.691 | 2.816 |
| 營業外收支淨額/利潤總額(%) | -0.457 | -1.242 | -0.871 | -0.073 | -0.165 | 償債能力分析 |
| 流動比率 (X) | 14.621 | 11.984 | 10.660 | 20.670 | 6.092 |
| 速動比率 (X) | 13.413 | 10.992 | 10.111 | 19.802 | 4.734 |
| 資產負債率 (%) | 5.812 | 7.457 | 8.895 | 4.614 | 12.805 |
| 帶息債務/全部投入資本 (%) | 0.647 | 0.932 | 2.985 | 0.271 | -- |
| 股東權益/帶息債務 (%) | 15,272.070 | 10,560.344 | 3,230.841 | 36,672.936 | 5,114.783 |
| 股東權益/負債合計 (%) | 1,620.605 | 1,241.104 | 1,024.271 | 2,067.151 | 680.967 |
| 利息保障倍數 (X) | -0.872 | -3.007 | -1.260 | 88.477 | 21.911 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 47.584 | 33.696 | 70.748 | 72.624 | 0.000 |
| 存貨周轉天數 (天) | 190.543 | 130.916 | 100.365 | 112.946 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 18/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
